Skip to content

The Effectiveness of Different Techniques of Interscalene Brachial Plexus Block With General Anesthesia for Shoulder Arthroscopy

The Effectiveness of Different Techniques of Interscalene Brachial Plexus Block With General Anesthesia for Shoulder Arthroscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04941235
Enrollment
80
Registered
2021-06-28
Start date
2018-05-01
Completion date
2020-08-31
Last updated
2021-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder and Upper Arm Injury

Keywords

shoulder arthroscopy

Brief summary

There are different techniques of interscalene brachial plexus block, we aimed to evaluate the effectiveness of 3 of them as analgesia during shoulder arthroscopy surgery under general anesthesia.

Detailed description

Prospective randomized controlled study There were 4 groups included in our study: Group N: nerve stimulator guided interscalene brachial plexus block was done Group U: ultrasound guided interscalene brachial plexus block was done Group NU: dual guidance (using both nerve stimulator and ultrasound) Group C: control group We assessed in each group: heart rate, noninvasive blood pressure, time needed for block, onset of sensory and motor power loss and their offset, and finally patient satisfaction.

Interventions

DEVICEultrasound and nerve stimulator

nerve stimulator and ultrasound guided interscalene brachial plexus block

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18-65 years old. * Sex: Both sexes. * ASA I & II.

Exclusion criteria

* \- Patient refusal. * Bleeding disorders. * Damage or disease of the brachial plexus. * ASA more than II. * Pre-existing peripheral neuropathy. * Patients with neuromuscular diseases. * Patients with known hypersensitivity to drugs of the study. * Patients with local skin infection at the site of injection. * Psychiatric diseases interfering with evaluation of the block.

Design outcomes

Primary

MeasureTime frameDescription
Analgesic effect of each technique12 hourusing visual analogue scale for pain The patient is asked to express the degree of pain in numbers from 0-10, where 0 means no pain and 10 represents severe pain.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026